LumiraDx Limited

NASDAQ (USD): LumiraDx Limited (LMDX)

Last Price

0.016

Today's Change

-0.018 (52.94%)

Day's Change

0.015 - 0.028

Trading Volume

120,553,903

Overview

Market Cap

249 Million

Shares Outstanding

15 Billion

Avg Volume

20,450,875

Avg Price (50 Days)

0.10

Avg Price (200 Days)

0.34

PE Ratio

-0.01

EPS

-1.08

Earnings Announcement

19-Mar-2024

Previous Close

0.03

Open

0.02

Day's Range

0.0151 - 0.0282

Year Range

0.0151 - 1.33

Trading Volume

120,553,903

Price Change Highlight

1 Day Change

0.00%

5 Day Change

21.21%

1 Month Change

-53.49%

3 Month Change

-83.25%

6 Month Change

-95.83%

Ytd Change

-67.55%

1 Year Change

-98.67%

3 Year Change

-99.84%

5 Year Change

-99.84%

10 Year Change

-99.84%

Max Change

-99.84%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment